Previously it has been shown that neutrophil elastase (NE) can induce interleukin-8 (IL-8) expression in bronchial epithelial cells (BECs). We have elucidated the intracellular mechanism by which this occurs. Time course and dose response studies showed that stimulation of 16HBE140-cells with N E (10 nM, 4h) induced maximal IL-8 promoter activity, IL-8 gene expression and IL-8 protein production as assessed by reporter gene assays, quantitative RT-PCRs and ELISAs, respectively. These responses were inhibited by actinomycin D, indicating a transciptional regulatory mechanism.
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Using electrophorestic mobility shift assays we demonstrated that NFkappaB, specifically the p50/65 heterodimer, was activated in reponse to N E and that this activation correlated with a concomitant degradation of IkappaB-P. In addition, interleukin-1 receptor-associated kinase (1RAK)was degraded following N E stimulation of 16HBE140-cells, implicating it as a signal transducer for N E in this pathway in human BECs. Interleukin-3 acts as a growth and survival factor for haemopoietic cells, activating many intracellular signalling cascades, including the phosphinositide 3-kinase (PI3K) pathway. Previously, we demonstrated that regulated expression of a dominant-negative mutant of class IA PI3Ks ( 6~8 5 ) caused a dramatic reduction in IL-3-induced proliferation, with little change in apoptosis, implicating PI3K as a key regulator of IL-3-mediated proliferation. We are now investigating the mechanism PI3K utilises to regulate IL-)-mediated proliferation. Expression of 6~8 5 , or treatment with LY294002, decreased IL-3-induced activation of MAPKs, slowed cell cycle progression and led to accumulation of cells in GI. Consistent with these findings, inhibition of PI3Ks caused a reduction in cyclin D3 levels and a decrease in IL-3-induced phosphorylation of the pocket proteins pRb, p130 and p107, all characteristic of a G1 arrest. These studies indicate that PI3K plays an important role in mediating Glk-phase cell cycle progression. To investigate the role played by the PI3K-binding protein Gab2 in these events, we expressed a Gab2 mutant deficient in PI3K binding. Expression of this mutant reulted in decreased phosphorylaton of endogenous Gab2 and reduced it's association with PI3K. We are currently investgating the effects of this mutant on IL-%driven proliferation and survival. Peyer's patches (PP) are portals for the surveillance of gut contents by the immune system. PP sample particulate antigens and microorganisms from the gut lumen and transfer them to the underlying mucosa-associated lymphoid tissue. PP lack a substantial mucus covering, which might otherwise obstruct antigen sampling. However, the viscoelastic properties of mucus are such that a gel might spread over PP from adjacent mucosa to form a continuous layer. We hypothesise that mucin-degrading enzymes dynamically remove such mucus over PP. Thus we examined activity of a range of glycosidases secreted by M cells or non-PP epithelial cells. Rat colon PP were mounted in Ussing chambers and incubated in 
